CLASS II Drug recall · Reported 20 Mar 2024 · FDA Enforcement Report

Potassium Chloride for Injection Concentrate USP, 500 mEq recalled

B. Braun Medical is recalling Potassium Chloride for Injection Concentrate USP, 500 mEq/ (2 mEq/mL), distributed nationwide in the US. The recall was initiated on 6 Mar 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: J2S007, Exp: 12/31/2024; J3A115, Exp: 01/31/2025.
NDC0264-1944
Quantity recalled22,752 bags

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0370-2024
FDA event ID
94184
Recalling firm
B. Braun Medical, Irvine, CA
Manufacturer
B. Braun Medical Inc.
Classification
Class II
Status
Terminated
Recall initiated
6 Mar 2024
FDA classified
8 Mar 2024
Reported
20 Mar 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

6 Mar 2024Recall initiated by company
8 Mar 2024Classified by FDA+2 days
20 Mar 2024Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of assurance of sterility: pinholes, within the blue label characters on the EXCEL bag, specifically within the dotted characters on the label, resulting in leaks.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Potassium Chloride for Injection Concentrate USP, 500 mEq/250 mL (2 mEq/mL), 250 mL Bag, Rx only, B. Braun Medical Inc., Bethlehem, PA 18018, NDC 0264-1944-20

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Lack of assurance of sterility: pinholes, within the blue label characters on the EXCEL bag, specifically within the dotted characters on the label, resulting in leaks.

Which lots are affected?

Lot #: J2S007, Exp: 12/31/2024; J3A115, Exp: 01/31/2025.

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from B. Braun Medical

All 447

Other Potassium Chloride recalls

All 23
ReportedClassRecallCompanyReasonWhere
DrugCLASS IPotassium Chloride Inj., 20 mEq total in Flexible Container recalledPotassium ChlorideOtsuka ICU MedicalOtherNationwide
DrugCLASS IPotassium Chloride Inj., 10 mEq total in Flexible Container recalledPotassium ChlorideOtsuka ICU MedicalOtherNationwide
DrugCLASS IPotassium Chloride Inj., 20 mEq total in flexible container recalledPotassium ChlorideICU MedicalLabeling ErrorsNationwide
DrugCLASS IPotassium Chloride Inj., 10 mEq total recalled by ICU MedicalPotassium ChlorideICU MedicalOtherNationwide
DrugCLASS IIPotassium Chloride Extended-Release Tablets, USP, 10 mEq recalledPotassium ChlorideThe Harvard Drug GroupPotency & AssayNationwide